Echinacea for preventing and treating the common cold
نویسندگان
چکیده
منابع مشابه
Echinacea for preventing and treating the common cold.
Echinacea preparations are widely used for common cold. Many consumers and healthcare professionals are not aware that products available under the term Echinacea may differ in their composition, due to the use of different species, plant parts, extraction methods and addition of other components. In 2005, a Cochrane review has been published to provide objective evidence whether the various Ec...
متن کاملEchinacea for treating the common cold: a randomized trial.
BACKGROUND Echinacea is widely used to treat the common cold. OBJECTIVE To assess the potential benefits of echinacea as a treatment of common cold. DESIGN Randomized, controlled trial. (ClinicalTrials.gov registration number: NCT00065715) SETTING Dane County, Wisconsin. PATIENTS 719 patients, aged 12 to 80 years, with new-onset common cold. INTERVENTION Patients were assigned to 1 of...
متن کاملVitamin C for Preventing and Treating the Common Cold
Background The role of vitamin C (ascorbic acid) in the prevention and treatment of the common cold has been a subject of controversy for 60 years, but is widely sold and used as both a preventive and therapeutic agent. Objective To discover whether oral doses of 0.2 g or more daily of vitamin C reduces the incidence, duration or severity of the common cold when used either as continuous prophy...
متن کاملVitamin C for Preventing and Treating the Common Cold
BACKGROUND The role of oral vitamin C (ascorbic acid) in the prevention and treatment of the common cold has been a subject of controversy for at least sixty years. Public interest in the topic continues to be high and vitamin C continues to be widely sold and used as a preventive and therapeutic agent for this common ailment. OBJECTIVES To discover whether oral vitamin C in doses of 200 mg o...
متن کاملEchinacea for Treating the Common ColdA Randomized TrialA Randomized Trial
Results: Of the 719 patients enrolled, 713 completed the protocol. Mean age was 33.7 years, 64% were female, and 88% were white. Mean global severity was 236 and 258 for the blinded and unblinded echinacea groups, respectively; 264 for the blinded placebo group; and 286 for the no-pill group. A comparison of the 2 blinded groups showed a 28-point trend (95% CI, 69 to 13 points) toward benefit f...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cochrane Database of Systematic Reviews
سال: 2014
ISSN: 1465-1858
DOI: 10.1002/14651858.cd000530.pub3